Daniel E. COHEN,Thomas J. PODSADECKI,Barry M. BERNSTEIN,Martin S. KING
申请号：
US13927814
公开号：
US20140024613A1
申请日:
2013.06.26
申请国别(地区):
US
年份:
2014
代理人:
摘要：
In one aspect, the present invention features HCV therapies comprising administering to a patient in need thereof an HCV protease inhibitor and ritonavir, wherein ritonavir is used as a pharmacokinetic booster to improve the pharmacokinetics of the HCV protease inhibitor. The HCV therapies do not require the testing of total cholesterol and triglyceride levels prior to and after the therapies.
